• Explore /
  • Poster
  • / A phase Ib study of pembrolizumab (Pem) in combination with stereotactic body radiotherapy (SBRT) for resectable liver metastatic colorectal cancer (CRC).

A phase Ib study of pembrolizumab (Pem) in combination with stereotactic body radiotherapy (SBRT) for resectable liver metastatic colorectal cancer (CRC).

Abstract Poster

Authors

null

Anita Ahmed Turk

Indiana University School of Medicine, Indiana University Simon Cancer Center, Indianapolis, IN

Anita Ahmed Turk , Sam Joseph Lubner , Nataliya Volodymyrivna Uboha , Noelle K. LoConte , Daniel Mulkerin , David H. Kim , Kristina Matkowskyj , Sharon M. Weber , Daniel Abbott , Jens C. Eickhoff , Michael F. Bassetti , Dustin A. Deming

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT02837263

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr 680)

DOI

10.1200/JCO.2019.37.4_suppl.680

Abstract #

680

Poster Bd #

N5

Abstract Disclosures

Similar Posters

First Author: Dustin A. Deming

First Author: Dustin A. Deming

First Author: Dustin A. Deming

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Phase I trial of perioperative chemotherapy plus immunotherapy in localized esophageal and gastroesophageal adenocarcinoma.

Phase I trial of perioperative chemotherapy plus immunotherapy in localized esophageal and gastroesophageal adenocarcinoma.

First Author: Mariela A. Blum Murphy